A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group

A total of 497 patients aged 18 to 56 years with insulin-dependent diabetes mellitus for 1 to 15 years were randomly assigned to take oral sorbinil or placebo and followed up for a median of 41 months. The percentage of patients whose retinopathy severity grade at maximum follow-up had worsened by two or more levels was not significantly different between the two treatment groups (28% in the sorbinil group and 32% in the placebo group, P = .344). The number of microaneurysms increased at a slightly slower rate in the sorbinil group than in the placebo group, with statistically significant differences at 21 (P = .046) and 30 (P = .039) months but not at the maximum follow-up (P = .156). About 7% of the patients assigned sorbinil developed a hypersensitivity reaction in the first 3 months. On the basis of these results, it is unlikely that sorbinil administered at a dosage of 250 mg daily for 3 years has a clinically important effect on the course of retinopathy in adults with insulin-dependent diabetes of moderate duration. Our data are consistent, however, with a slightly slower progression rate in the microaneurysm count among patients assigned to take sorbinil, a finding of uncertain clinical importance.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of the Polyol Pathway in High Glucose-Induced Apoptosis of Retinal Pericytes and Proliferation of Endothelial Cells
Takamura et al.
IOVS 2008;49:3216-3223.
ABSTRACT | FULL TEXT  

Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes
Zhang et al.
IOVS 2008;49:732-742.
ABSTRACT | FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun et al.
Diabetes 2006;55:2757-2762.
ABSTRACT | FULL TEXT  

Analysis of glucose metabolism in diabetic rat retinas
Ola et al.
Am. J. Physiol. Endocrinol. Metab. 2006;290:E1057-E1067.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Fong et al.
Diabetes Care 2004;27:2540-2553.
FULL TEXT  

Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher et al.
Diabetes 2004;53:2404-2411.
ABSTRACT | FULL TEXT  

Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study
Millen et al.
Am. J. Clin. Nutr. 2004;79:865-873.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Frank
NEJM 2004;350:48-58.
FULL TEXT  

Effects of Aldose Reductase Inhibitors and Galactose Withdrawal on Fluorescein Angiographic Lesions in Galactose-Fed Dogs
Cusick et al.
Arch Ophthalmol 2003;121:1745-1751.
ABSTRACT | FULL TEXT  

Biochemical Pathways for Microvascular Complications of Diabetes Mellitus
Setter et al.
The Annals of Pharmacotherapy 2003;37:1858-1866.
ABSTRACT | FULL TEXT  

Effect of Intravenous Administration of Sodium-Lactate on Retinal Blood Flow in Healthy Subjects
Garhofer et al.
IOVS 2003;44:3972-3976.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
Ciulla et al.
Diabetes Care 2003;26:2653-2664.
ABSTRACT | FULL TEXT  

A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat
Asnaghi et al.
Diabetes 2003;52:506-511.
ABSTRACT | FULL TEXT  

Correlation between erythrocyte aldose reductase level and human diabetic retinopathy
Oishi et al.
Br. J. Ophthalmol. 2002;86:1363-1366.
ABSTRACT | FULL TEXT  

Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz and King
JAMA 2002;288:2579-2588.
ABSTRACT | FULL TEXT  

Review: Thirty-seven years with diabetic retinopathy
Kohner
British Journal of Diabetes & Vascular Disease 2002;2:452-456.
ABSTRACT  

Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin
Kern and Engerman
Diabetes 2001;50:1636-1642.
ABSTRACT | FULL TEXT  

Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT  

Metabolic cataracts in newly diagnosed diabetes
Datta et al.
Arch. Dis. Child. 1997;76:118-120.
ABSTRACT | FULL TEXT  

Prevention and Treatment of the Complications of Diabetes Mellitus
Clark and Lee
NEJM 1995;332:1210-1217.
FULL TEXT